# Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

> **NCT04014166** · NA · COMPLETED · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 18 (actual)

## Conditions studied

- Thrombocytopenia
- Mesenchymal Stem Cells

## Interventions

- **OTHER:** Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)

## Key facts

- **NCT ID:** NCT04014166
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-21
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-06-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014166, "Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04014166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*